LymPro's first Pharma customer, to be announced sh
Post# of 30029
Posted On: 02/12/2015 3:45:44 PM
LymPro's first Pharma customer, to be announced shortly (In February) will be the first REVENUE GENERATING type of catalyst! The revenue from that announcement may still be several months off, nevertheless, it will be the start of something that all of us know will be really big one day!! Maybe in March we will get another Pharma signing up. And in April we get 2, and in May another 2, and so on and so forth.
We'll also be getting Georgetown blood tests joining in probably by summer time. We'll also be getting CLIA in the next 2 or 3 months. Those will accelerate the revenue from our Alzheimer's diagnostics.
What we don't know is when the MSPrecise diagnostic will start generating revenue. My impression was that we were doing a Validation for it that was only going to take about 3 months (starting a month ago) and that it would be ready to go after that. Certainly by May or June. Also, it won't take as long to ramp up to major revenue as the Alzheimer's diagnostics will.
I think in the next month if we get good news on the diagnostic revenue above, plus we get a grant to help pay for Eltoprazine, that should start moving the stock upward. I won't venture a guess as to how high as none of my past forecasts, nor anyone's else's, have been very accurate.
I'm thinking a buy out of the diagnostic division is premature in 2015. By mid 2016 it may make more sense/cents!! Right now I'm thinking an IPO might be the way to go. Hopefully we can get the pps up to the .20 cent level by May or June so we can up list and do the IPO then.
We're slowly building critical mass. One day the pps will start getting traction.
We'll also be getting Georgetown blood tests joining in probably by summer time. We'll also be getting CLIA in the next 2 or 3 months. Those will accelerate the revenue from our Alzheimer's diagnostics.
What we don't know is when the MSPrecise diagnostic will start generating revenue. My impression was that we were doing a Validation for it that was only going to take about 3 months (starting a month ago) and that it would be ready to go after that. Certainly by May or June. Also, it won't take as long to ramp up to major revenue as the Alzheimer's diagnostics will.
I think in the next month if we get good news on the diagnostic revenue above, plus we get a grant to help pay for Eltoprazine, that should start moving the stock upward. I won't venture a guess as to how high as none of my past forecasts, nor anyone's else's, have been very accurate.
I'm thinking a buy out of the diagnostic division is premature in 2015. By mid 2016 it may make more sense/cents!! Right now I'm thinking an IPO might be the way to go. Hopefully we can get the pps up to the .20 cent level by May or June so we can up list and do the IPO then.
We're slowly building critical mass. One day the pps will start getting traction.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼